Stephanie Bronstrup has over 15 years of clinical research experience with 13 of those years extensively focused in Oncology.  Mrs. Bronstrup has Hematology & Solid Tumors experience, inclusive of Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Cholangiocarcinoma, Colorectal Cancer, Glioblastoma, Hepatic Impairment, Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome, Ovarian Cancer, Prostate Cancer, Renal Cell Cancer and Hepatic Impairment.  In the Global Clinical Lead capacity, Mrs. Bronstrup worked on rare diseases such as Cholangiocarcinoma, a phase 3 study that treated locally advanced or metastatic cholangiocarcinoma harboring FGFR2 gene arrangements. Mrs. Bronstrup also has experience not only monitoring but also with managing First in Human studies along with Phases 1, 2 and 3.  Mrs. Bronstrup worked on the very first study that introduced a pill format of chemotherapy to patients.

Mrs. Bronstrup has worked alongside many different sites all over the United States and globally and has strong site relationships that she continues to provide outreach to. Throughout her many years in oncology research, Mrs. Bronstrup has worked on multiple studies that have included RECIST 1.0, 1.1, WHO criteria, Fluorescence in situ hybridization (FISH) Analysis/Cytogenetics, reviewing multiple biomedical imaging techniques and reports as well imaging biomarkers. She is very experienced in overcoming one of the challenges of working in early phase oncology, which is ensuring the sites’ capacity to obtain the multiple lab samples needed for analysis, especially if there are multiple Pharmacokinetic sample timepoints to obtain.

Prior to joining Rho as a Senior Clinical Team Lead, Mrs. Bronstrup held the positions of Research Associate, Project Research Associate, Clinical Research Associate (CRA), Senior CRA, Lead CRA, Clinical Team Lead, Senior Clinical Team Lead, and Global Clinical Lead. Over the course of her career, Mrs. Bronstrup has led and/or been involved with the following: site identification and selection, management of CRAs – including leadership of multiple global clinical study teams, development of clinical protocols, case report and other data collections forms, informed consent forms, site and monitor training tools, and clinical monitoring plans.

Why Oncology?

“One of the most powerful things to hear is a patient ringing the bell with the great accomplishment of finishing treatment.  I love being a part of helping improve patient’s lives and assisting in the research for a cure.”

What drives Stephanie?

“Being able to see the big picture and know that the work you do has an impact on helping and benefiting others.”